Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

proE-cad178-Luc Citations (5)

Originally described in: E-cadherin is transcriptionally activated via suppression of ZEB1 transcriptional repressor by small RNA-mediated gene silencing.
Mazda M, Nishi K, Naito Y, Ui-Tei K PLoS One. 2011;6(12):e28688. doi: 10.1371/journal.pone.0028688. Epub 2011 Dec 21.
PubMed Journal

Articles Citing proE-cad178-Luc

Articles
Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb. Egger JV, Lane MV, Antonucci LA, Dedi B, Krucher NA. Cancer Biol Ther. 2016 Nov;17(11):1197-1205. Epub 2016 Sep 19. PubMed
Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases. Park J, Kim DH, Shah SR, Kim HN, Kshitiz, Kim P, Quinones-Hinojosa A, Levchenko A. Nat Commun. 2019 Jun 26;10(1):2797. doi: 10.1038/s41467-019-10729-5. PubMed
SUMOylation of E2F1 Regulates Expression of EZH2. Du L, Fakih MG, Rosen ST, Chen Y. Cancer Res. 2020 Oct 1;80(19):4212-4223. doi: 10.1158/0008-5472.CAN-20-1259. Epub 2020 Aug 14. PubMed
Squamous cell carcinoma subverts adjacent histologically normal epithelium to promote lateral invasion. Singh P, Banerjee R, Piao S, Costa de Medeiros M, Bellile E, Liu M, Damodaran Puthiya Veettil D, Schmitd LB, Russo N, Danella E, Inglehart RC, Pineault KM, Wellik DM, Wolf G, D'Silva NJ. J Exp Med. 2021 Jun 7;218(6). pii: 211968. doi: 10.1084/jem.20200944. PubMed
The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer. Rigillo G, Belluti S, Campani V, Ragazzini G, Ronzio M, Miserocchi G, Bighi B, Cuoghi L, Mularoni V, Zappavigna V, Dolfini D, Mercatali L, Alessandrini A, Imbriano C. Cancer Lett. 2023 Jul 28;567:216262. doi: 10.1016/j.canlet.2023.216262. Epub 2023 Jun 10. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.